Pharmaceutical microbiology: key developments 2022
European Pharmaceutical Review
JANUARY 16, 2023
He warned, “Implementation of a CCS will require more than writing documents.”. The safety and efficacy of mRNA vaccines should be a game changer and is the likely solution to antibiotic-resistant microorganisms and emerging viral pathogens.” Perhaps we will see a universal flu vaccine in the near future.
128 
Let's personalize your content